Company A - an OTCBB listed company in the medical information technology space. Carpe DM wrote and executed a comprehensive IR/PR program. Carpe DM introduced Company A to several fund managers and research analysts. Stock price initially traded in the $1.20 price range. After 2+ years stock price reached $22 and the company was acquired by a private equity firm for more that 16x the original marketcap.
Company B - Biotech company trading on the OTCBB. Carpe DM engaged in a comprehensive IR and capital raising campaign. The company was able to uplist to Nasdaq and immediately raised over $60 Million through contacts initiated by Carpe DM. After the capital raise the company was a acquired by a top tier Biotech company
Company C - A cold chain shipping solution was originally listed on the Pinksheets. Through strategic initiatives deployed by Carpe DM, Company C was able to uplist to Nasdaq. Our strategy included raising significant capital, introductions to analysts and institutional investors and key potential customers. Company's market cap increased over 10x during our work period.
Company D - An environmental emissions control company. Raised initial round of $5 million to help company acquire key manufacturer. Introduced company to several investment banking firms. Introduced the company to several prospective customers and key governmental agencies.
Company E - Unknown medical device company trading on a foreign exchange and the grey sheets in the US. Assisted the Company getting listed on Nasdaq, helped raise in excess of $100 million, got 2 of 3 required market makers to be part of the listing process. Introduced the company to its first analyst coverage and proper investment banks. Secured deals and termsheets on short notice to help company raise significant additional secondary funds when required. Introduced company to key acquisition to establish US manufacturing. Introduced Company to key FDA consultant.